Skip to main content

Lauren Ann Seno

Pronouns: She/Her

Lauren partners extensively with diverse industry clients to understand the intersection between health policy and business strategy.

Lauren is a director of Health Care Strategy at NORC and brings 12 years of experience in the health care industry, with a focus on policy research and analysis, payment systems, and the intersection of policy and business strategy. She’s held roles in both the private and public sectors, providing expertise to clients such as provider organizations, foundations, associations, and government entities.

At NORC, Lauren has a proven track record of delivering high-quality projects and providing technical expertise to cross-sector clients. Her recent portfolio of work includes a comprehensive survey on the collection, access, sharing, and use of data on the social determinants of health, analyzing the impact of price transparency policies and data, and modeling the possible benefits of early cancer detection to Medicare program finances. Additionally, Lauren oversees project delivery teams, providing technical input and direction to staff implementing complex solutions to meet client expectations.

Prior to joining NORC, Lauren was a Managing Consultant with Guidehouse (formerly Navigant Consulting) where she managed multi-million-dollar client engagements focused on alternative payment model adoption, with a specific focus on CMS (Medicare/Medicaid) programs, including ACOs, MACRA, Direct Contracting, BPCI-A, and sub-capitation agreements. As part of this work, she conducted in-depth analyses of payment policy and health system claims data to inform strategic choices about Federal and state reimbursement program participation.

Project Contributions

Workforce Challenges & Technology Adoption for Health Information Professionals

Examining the current state of the health information workforce and the use of artificial intelligence

Client:

American Health Information Management Association

Drug Pricing Explained

Examining the path to market of five prescription medications to understand the forces that shape the cost of treatments

Client:

Arnold Ventures